diphenyleneiodonium has been researched along with ciglitazone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dai, J; Remick, DG; Wang, X; Zeng, X | 1 |
Hong, DW; Hong, SH; Kim, TW; Park, JW | 1 |
2 other study(ies) available for diphenyleneiodonium and ciglitazone
Article | Year |
---|---|
Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes.
Topics: Antioxidants; Cells, Cultured; Chemokine CCL2; Chromans; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation; Genistein; Homocysteine; Humans; Imidazoles; Indoles; Interleukin-8; Monocytes; Naphthalenes; Onium Compounds; Pyridines; Pyrrolidines; Reactive Oxygen Species; RNA, Messenger; Sulfonamides; Thiazoles; Thiazolidinediones; Thiocarbamates; Time Factors; Troglitazone; Tyrphostins | 2003 |
CB11, a novel purine-based PPARÉ£ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cells.
Topics: 3T3 Cells; Adipocytes; Anilides; Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Azo Compounds; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase 9; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line, Tumor; DNA Damage; Epithelial-Mesenchymal Transition; Female; Humans; Imidazoles; L-Lactate Dehydrogenase; Ligands; Luciferases; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Onium Compounds; PPAR gamma; Purines; Radiation Tolerance; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Thiazolidinediones; Tumor Burden; Tumor Suppressor Protein p53 | 2020 |